Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Intravascular malignant lymphomatosis]

H Mertz1, V H Danchell

  • 1Aalborg Sygehus, patologisk institut.

Ugeskrift for Laeger
|January 7, 1998
PubMed
Summary

Intravascular malignant lymphomatosis (IML) is a rare lymphoma. Early diagnosis and chemotherapy offer potential for remission in this aggressive condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polythelia in a 13-year old girl.

Il Giornale di chirurgia·2017
Same author

Comparative Evaluation of the Q3 and Hybrid III 3-Year-Old Dummies in Biofidelity and Static Out-of-Position Airbag Tests.

Stapp car crash journal·2007
Same author

The influence of superficial soft tissues and restraint condition on thoracic skeletal injury prediction.

Stapp car crash journal·2007
Same author

Physician knowledge of Rome symptom criteria for irritable bowel syndrome is poor among non-gastroenterologists.

Neurogastroenterology and motility·2006
Same author

Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome.

Gut·2005
Same author

Review article: visceral hypersensitivity.

Alimentary pharmacology & therapeutics·2003

Area of Science:

  • Oncology
  • Hematology
  • Pathology

Background:

  • Intravascular malignant lymphomatosis (IML) is a rare extranodal non-Hodgkin lymphoma.
  • Characterized by malignant lymphoid cell proliferation within small blood vessel lumens.

Observation:

  • A case of IML presented with non-specific pulmonary symptoms, weight loss, and fever.
  • Cardiac, cerebral, and skin lesions developed subsequently.
  • The patient died within six months, with diagnosis confirmed at autopsy.

Findings:

  • IML diagnosis was established post-mortem.
  • The condition presented with a complex and evolving set of symptoms mimicking various organ ischemia.

Implications:

  • Standard chemotherapy for high-grade lymphomas may achieve remission and long-term survival.
  • IML should be considered in the differential diagnosis of unexplained ischemic symptoms affecting multiple organs.

Related Experiment Videos